Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
NCT00532285
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
44
Enrollment
OTHER_GOV
Sponsor class
Stopped
terminated
Conditions
Breast Cancer
Interventions
DRUG:
Paclitaxel/Gemcitabine
Sponsor
National Cancer Center, Korea